KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Leases (2018 - 2025)

Astrana Health's Leases history spans 8 years, with the latest figure at $33.9 million for Q3 2025.

  • For Q3 2025, Leases rose 2.47% year-over-year to $33.9 million; the TTM value through Sep 2025 reached $33.9 million, up 2.47%, while the annual FY2024 figure was $32.6 million, 12.82% down from the prior year.
  • Leases for Q3 2025 was $33.9 million at Astrana Health, up from $30.6 million in the prior quarter.
  • Across five years, Leases topped out at $39.2 million in Q1 2024 and bottomed at $400000.0 in Q1 2021.
  • The 5-year median for Leases is $18.4 million (2023), against an average of $18.5 million.
  • The largest annual shift saw Leases plummeted 97.8% in 2021 before it soared 3592.5% in 2022.
  • A 5-year view of Leases shows it stood at $1.3 million in 2021, then skyrocketed by 1472.62% to $20.4 million in 2022, then skyrocketed by 82.92% to $37.4 million in 2023, then fell by 12.82% to $32.6 million in 2024, then grew by 4.09% to $33.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Leases are $33.9 million (Q3 2025), $30.6 million (Q2 2025), and $1.2 million (Q1 2025).